The X Factor: A Panel Discussion on Successful Leadership Development Programs

The X Factor: A Panel Discussion on Successful Leadership Development Programs

In today’s fast paced, ever changing world, leaders--now more than ever--need to unlock the talent of everyone on their teams—no matter what their difference.  It is by unlocking the best thinking and experiences because of who we are and what we know that allows companies to create value and drive performance in our consumer-led world.  So….is that even possible? 

Join the conversation and hear how one multi-national company has created an award-winning framework that accelerates the career advancement of talent from different genders and ethnic backgrounds.  Learn how to initiate a practical approach to creating systemic change from the original designer.  Gain insights about the “X” factor and why it works from graduates of the program in a panel discussion. 

If you want to make a difference by developing diverse talent where you work, you will want to join the dialogue.

Presenter: 

Stephanie Trotter, Executive Coach
GSK

Stephanie Trotter is an internal executive coach at GSK. With diverse experiences as a business leader, organizational development consultant, in talent management, and leadership development, she supports the transformational growth of leaders at GSK. While being a collaborative coach, she challenges her clients to have the courage to explore who they are, what is important to them, and pursue their dreams.  Stephanie is known to be a strong strategic thinker while grounded in practical business approaches and a solution-oriented mind set. 

Real world experiences shape her coaching from her background as a sales leader who has worked in the trenches. Her coaching clients vary from women in leadership to senior executives in R&D, the commercial organization, IT, and human resources.  What energizes Stephanie the most about coaching is seeing people become more powerful when they tap into their potential, live their purpose, and pursue their passions.

As a member of the coaching team, she contributes to GSK’s award-winning coaching initiatives by shaping the design of the Accelerating Differences program, training Job Plus coaches, and partnering with leaders to use new and different coaching approaches to meet their business needs.

Her passion is spending time with her family going to the beach, bike riding, or being a soccer mom for Jonathan (11) and Emily (10).

Her coaching experiences include:

• Co-create a conversation with leaders to define an inspiring vision, strategies, and prioritize what they need to focus on to deliver real business results
• Trusted coach and advisor to senior executives who want to create a high-performance culture
• Partner with VPs and Sr. VPs to accelerate transitions into broader leadership roles
• Support women in leadership who want to achieve their career ambitions, while being true to themselves and focusing on what matters most to them
  
  

 Meet our panelists: 


Dharmesh Bhanushali, Biotech Development Lead, class of 2018

Dharmesh Bhanushali, Ph.D., is Senior Director, Biopharm CMC Licensing and Externalization within the Biopharm Product Development and Supply (BPDS) organization in Pharmaceuticals Research & Development at GlaxoSmithKline.  In his current role Dharmesh has single point accountability to lead BPDS’s business interactions with strategic external partners to successfully deliver our ambition for increased externalization while supporting aggressive asset and technology in-licensing efforts. 

Dharmesh has over 16 years of experience in the pharmaceutical industry spanning small and large molecules.  Dharmesh joined GSK in 2002 in the former Chemical Development group, working in the process engineering function where he developed processes for small molecule synthesis and also served as Chemical Development Project Leader responsible for the development, technology transfer and validation of a drug substance manufacturing process for a late stage oncology asset which was commercialized in 2009. He joined the Biopharm CMC organization in 2010 to support the development of novel antibodies. In March 2012, he took on the role of Director, Process Technology where he led an aligned team for ensuring timely and successful technology transfer, process troubleshooting, and manufacture of bulk drug substance as required supporting the Biopharm R&D early phase portfolio (microbial and mammalian assets).  In his most recent role as Biopharm Technology Development Lead in AMT, Dharmesh built the Biopharm AMT group which had the accountability for coordinating the seek, incubate and industrialization of new technologies supporting biopharma CMC clinical and commercial manufacture. 

Dharmesh received a Bachelor in Chemical Engineering from University of Bombay after which he went on to receive a Ph.D. in Chemical Engineering from University of Kentucky. 



Celeste Ferreira-Cornwell, Sr. Clinical Development Director, class of 2018

M. Celeste Ferreira-Cornwell is the Head of Clinical Scientists in the Immuno Inflammation Clinical Science group at GlaxoSmithKline (GSK). She has over 21 years of early discovery & clinical development experience (e.g., anti-infectives, dermatology, endocrinology, gastroenterology, neuroscience, and psychiatry). She started her pharmaceutical career at SmithKline Beecham as Research Investigator and subsequently, transitioned to Clinical Development. Prior to returning to GSK in 2016, Celeste was a Clinical Programs Group Lead Director at Shire.  Both at GSK and Shire, Celeste held positions as a Clinical Development/Project Lead and line managed groups in various therapeutic areas. She had a key role in various submissions leading to successful approvals. Celeste received her BS in Biology from Gwynedd-Mercy University; MA and PhD in Development and Cell Biology (Biology) from Temple University. Subsequently, she completed three postdoctoral fellowships at Dana Farber Cancer Institute/Harvard Medical School, Thomas Jefferson University and University of Pennsylvania.

Valerie Reynaert serves as the Head of Clinical Operations for the Americas region at GlaxoSmithKline. She joined GSK in 2000 and spent more than 15 years in clinical development and operations in a variety of leadership roles in GSK’s Vaccines business in both Europe and the US. Within her last role in Vaccines she was the Head of Global study delivery. Valerie moved to GSK’s Pharma business in 2015 where she is currently responsible for the regional delivery of GSK Pharma’s clinical trials portfolio. She has a Masters in Medical and Social Sciences from the Catholic University of Leuven, Belgium.  

In addition to her line responsibilities, Valerie leads the Women Leadership initiative for the GSK Upper Providence site. She sits on the Clinical Leader editorial board and is a linking leader board member. 

Valerie lives in Radnor PA with her 3 boys Mathieu (15) ,Maxime (12) and Sebastian (5), husband Mikael and dog Winston. She likes to play tennis and paddle and spends her weekends at the lake.